Clinical Trial Update: Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg [Phase 1]

View source ↗

Summary

Phase 1 PK study comparing HCP1201 alone versus co-administration with Metformin SR 750mg and Rosuvastatin 10mg for Diabetes Mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HCP1201
• Metformin SR 750mg (metformin)
• Rosuvastatin 10mg (rosuvastatin)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED